Boehringer Ingelheim Pharmaceuticals announced Monday it has entered an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical's Fort Dodge Animal Health business.
Boehringer, which has nearly 3,000 employees in Connecticut, is expected to acquire the Fort Dodge assets once the Pfizer-Wyeth merger is complete.
In addition to its branded pharmaceuticals business, Boehringer's divisions include generic drugs, chemicals, consumer products and animal health the last two of which are also based in Ridgefield.
No comments:
Post a Comment